Sensus Healthcare, Inc.
SRTS
$4.58
$0.132.92%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.97% | 126.76% | 104.09% | 212.33% | -4.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.97% | 126.76% | 104.09% | 212.33% | -4.10% |
| Cost of Revenue | 25.84% | 88.53% | 100.00% | 123.27% | -0.38% |
| Gross Profit | -9.26% | 163.45% | 107.06% | 310.73% | -6.22% |
| SG&A Expenses | 142.17% | 2.89% | -11.94% | -17.73% | -47.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.23% | 26.77% | 28.35% | 22.40% | -21.74% |
| Operating Income | -69.05% | 178.89% | 275.87% | 198.23% | 33.68% |
| Income Before Tax | -66.30% | 212.56% | 348.41% | 215.02% | 31.72% |
| Income Tax Expenses | -74.29% | 547.20% | 215.34% | 203.12% | 1.08% |
| Earnings from Continuing Operations | -63.28% | 183.74% | 524.21% | 220.06% | 48.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.28% | 183.74% | 524.21% | 220.06% | 48.82% |
| EBIT | -69.05% | 178.89% | 275.87% | 198.23% | 33.68% |
| EBITDA | -67.87% | 184.36% | 292.82% | 203.18% | 32.74% |
| EPS Basic | -63.43% | 183.41% | 522.65% | 219.73% | 50.23% |
| Normalized Basic EPS | -66.46% | 209.16% | 347.79% | 214.66% | 32.98% |
| EPS Diluted | -63.43% | 177.78% | 522.65% | 216.33% | 50.23% |
| Normalized Diluted EPS | -66.64% | 209.00% | 347.20% | 214.56% | 34.18% |
| Average Basic Shares Outstanding | 0.39% | 0.31% | 0.30% | 0.31% | -0.94% |
| Average Diluted Shares Outstanding | 1.04% | 0.46% | 0.52% | 0.45% | -1.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
